TY - JOUR AB - Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 1D on p. 4392, in the 0 h row the ‘Scramble’ and ‘mimic’ panels appeared to feature overlapping data. After having re‑examined their data, the authors realize that the Figure had been assembled incorrectly, and they were able to identify the correct image for the ‘Scramble’ panel. The corrected version of Fig. 1, including the corrected data for Fig. 1D, is shown below. Note that the error made in this Figure did not affect the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors thank the Editor of Oncology Letters for presenting them with the opportunity to publish this Corrigendum, and apologize to the Editor and to the readership of the Journal for any inconvenience caused. [the original article was published in Oncology Letters 15: 4390-4396, 2018; DOI: 10.3892/ol.2018.7900] AD - Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, Jiangxi 330006, P.R. China AU - Ye,Conglin AU - Yu,Xiaolong AU - Liu,Xuqiang AU - Dai,Min AU - Zhang,Bin DA - 2021/02/01 DO - 10.3892/ol.2020.12394 IS - 2 JO - Oncol Lett KW - microRNA‑30d Ewing's sarcoma invasion and migration apoptosis mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase phosphoinositide 3‑kinase/Akt PY - 2021 SN - 1792-1074 1792-1082 SP - 133 ST - [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro T2 - Oncology Letters TI - [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro UR - https://doi.org/10.3892/ol.2020.12394 VL - 21 ER -